Build capacity for agile internationalisation through co-creation and co-design via individual training and coaching tailored to the needs of biomedical technology, medical technology, biotech and pharma industry.
 

The assessment will map the development process, considering its current TRL level and the value chain, including customers, competitors, public authorities, and other stakeholders relevant to the development, approval, adaptation, and implementation of the innovation. Key features: 

• Market-specific trends and business opportunities.
• Assessment of technological, market, financial, and clinical feasibility aspects.
• Market-specific requirements for the development and market access stage.
• Benefits for EIC beneficiaries in i) research stage, ii) spinout/startup, iii) scale-up:
• Accelerate the R&D process by ensuring that the product meets the needs, processes and environment of multinational customers.
• Gain an understanding of how to adapt the product for multinational markets and implement the adaptation agilely in healthcare units, biomedical facilities or clinical environments.
• Gain an understanding of where the innovation may have the most need, its safety, efficacy, and cost-effectiveness in its user environment that, in turn, will give a competitive edge and marketing advantage.
   

The aim is to accelerate the innovation development process from its current TRL to market, create an agile approach and provide expertise to build a value chain that fits the ecosystem. 
 

The service is directed to EIC pathfinder, EIC transition and EIC accelerator innovators by dedicated in-house or external experts depending on the target market via online, offline or hybrid models.